Your browser doesn't support javascript.
loading
Absence of MHC-II expression by lymph node stromal cells results in autoimmunity.
Dubrot, Juan; Duraes, Fernanda V; Harlé, Guillaume; Schlaeppi, Anjalie; Brighouse, Dale; Madelon, Natacha; Göpfert, Christine; Stokar-Regenscheit, Nadine; Acha-Orbea, Hans; Reith, Walter; Gannagé, Monique; Hugues, Stephanie.
Afiliação
  • Dubrot J; Department of Pathology and Immunology, School of Medicine, University of Geneva, Geneva, Switzerland.
  • Duraes FV; Department of Pathology and Immunology, School of Medicine, University of Geneva, Geneva, Switzerland.
  • Harlé G; Department of Pathology and Immunology, School of Medicine, University of Geneva, Geneva, Switzerland.
  • Schlaeppi A; Department of Pathology and Immunology, School of Medicine, University of Geneva, Geneva, Switzerland.
  • Brighouse D; Department of Pathology and Immunology, School of Medicine, University of Geneva, Geneva, Switzerland.
  • Madelon N; Department of Pathology and Immunology, School of Medicine, University of Geneva, Geneva, Switzerland.
  • Göpfert C; Division of Rheumatology, Department of Internal Medicine, University Hospital Geneva, Geneva, Switzerland.
  • Stokar-Regenscheit N; Institute of Animal Pathology, Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
  • Acha-Orbea H; Institute of Animal Pathology, Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
  • Reith W; Department of Biochemistry, University of Lausanne, Epalinges, Switzerland.
  • Gannagé M; Department of Pathology and Immunology, School of Medicine, University of Geneva, Geneva, Switzerland.
  • Hugues S; Department of Pathology and Immunology, School of Medicine, University of Geneva, Geneva, Switzerland.
Life Sci Alliance ; 1(6): e201800164, 2018 Dec.
Article em En | MEDLINE | ID: mdl-30584641
ABSTRACT
How lymph node stromal cells (LNSCs) shape peripheral T-cell responses remains unclear. We have previously demonstrated that murine LNSCs, lymphatic endothelial cells (LECs), blood endothelial cells (BECs), and fibroblastic reticular cells (FRCs) use the IFN-γ-inducible promoter IV (pIV) of the MHC class II (MHCII) transactivator CIITA to express MHCII. Here, we show that aging mice (>1 yr old) in which MHCII is abrogated in LNSCs by the selective deletion of pIV exhibit a significant T-cell dysregulation in LNs, including defective Treg and increased effector CD4+ and CD8+ T-cell frequencies, resulting in enhanced peripheral organ T-cell infiltration and autoantibody production. The proliferation of LN-Tregs interacting with LECs increases following MHCII up-regulation by LECs upon aging or after exposure to IFN-γ, this effect being abolished in mice in which LECs lack MHCII. Overall, our work underpins the importance of LNSCs, particularly LECs, in supporting Tregs and T-cell tolerance.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article